Piercing and Crohn's disease.

The new global map of human brucellosis. Lancet Infect Dis (2006) 12.83

Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol (2004) 3.28

European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis (2013) 3.01

Association of Helicobacter pylori infection with cardiovascular disease--is it just a myth? Eur J Intern Med (2010) 1.67

The edematogenic properties of insulin. Am J Kidney Dis (2004) 1.55

Octreotide in the treatment of refractory ascites of cirrhosis. Scand J Gastroenterol (2006) 1.55

Increased fatigability of external anal sphincter in inflammatory bowel disease: significance in fecal urgency and incontinence. J Crohns Colitis (2010) 1.42

Thrombocytopenia associated with chronic liver disease: effects of rifaximin on platelet count. Am J Gastroenterol (2010) 1.41

Unexplained hypertransaminasaemia: clue to diagnosis of Addison's disease. Eur J Gastroenterol Hepatol (2002) 1.40

Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Dig Dis Sci (2005) 1.38

Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis (2007) 1.33

Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis (2009) 1.22

Jaundice of unknown origin: Remember zoonoses! Scand J Gastroenterol (2006) 1.13

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflamm Bowel Dis (2012) 1.08

On the probable association of adalimumab and diffuse retinopathy in a patient with Crohn's disease. J Crohns Colitis (2012) 1.06

Health literacy in the field of infectious diseases: the paradigm of brucellosis. J Infect (2006) 1.02

Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol (2012) 1.01

The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis (2004) 1.01

The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol (2005) 1.00

Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. Clin Gastroenterol Hepatol (2012) 0.97

Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites. J Hepatol (2006) 0.96

Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. J Crohns Colitis (2009) 0.95

Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature. Scand J Gastroenterol (2006) 0.94

Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis. Hepatology (2012) 0.93

Inflammatory bowel disease and lupus: a systematic review of the literature. J Crohns Colitis (2012) 0.92

Characteristics of ascitic fluid in cardiac ascites. Scand J Gastroenterol (2007) 0.90

Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid-induced lipotoxicity in liver cells. FEBS J (2010) 0.88

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis (2011) 0.87

Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis (2014) 0.87

A family report of Crohn's disease in three children immigrating from Albania to Greece and review of the literature. J Crohns Colitis (2010) 0.86

Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters. Eur J Gastroenterol Hepatol (2003) 0.86

Sjogren's syndrome in a patient with ulcerative colitis and primary sclerosing cholangitis: Case report and review of the literature. J Crohns Colitis (2009) 0.85

Splenic marginal zone lymphoma in a patient with chronic hepatitis B. J Gastrointestin Liver Dis (2009) 0.85

Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study. Inflamm Bowel Dis (2015) 0.84

Alarming atrioventricular block and mitral valve prolapse in the Kearns-Sayre syndrome. Int J Cardiol (2002) 0.84

The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. J Clin Gastroenterol (2006) 0.84

Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites. Nephrol Dial Transplant (2005) 0.84

Do we really understand what the immunological disturbances in inflammatory bowel disease mean? World J Gastroenterol (2009) 0.84

New prognostic markers for outcome of acute pancreatitis: overview of reporting in 184 studies. Pancreas (2011) 0.83

Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia. Liver Int (2011) 0.83

Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol (2007) 0.83

Concurrent development of spontaneous pyomyositis due to Staphylococcus epidermidis and Kikuchi-Fujimoto disease. Intern Med (2008) 0.82

Polymyalgia rheumatica associated with neck surgery. South Med J (2009) 0.82

Intravenous iron therapy restores functional iron deficiency induced by infliximab. J Crohns Colitis (2007) 0.82

Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features. Int J Colorectal Dis (2004) 0.81

Red face, postendoscopy. BMJ Case Rep (2011) 0.81

Hypouricemia in individuals admitted to an inpatient hospital-based facility. Am J Kidney Dis (2003) 0.81

Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. J Crohns Colitis (2010) 0.81

Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin. Eur J Intern Med (2008) 0.81

Acute Haemophilus parainfluenzae endocarditis: a case report. J Med Case Rep (2009) 0.80

Small bowel adenocarcinoma presenting as a first manifestation of Crohn's disease: report of a case, and a literature review. Eur J Gastroenterol Hepatol (2002) 0.80

Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study. Angiology (2011) 0.80

Pseudomonas fluorescens infections in clinical practice. Scand J Infect Dis (2006) 0.80

Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. J Crohns Colitis (2007) 0.80

Non-toxic megacolon due to transverse and sigmoid colon volvulus in a patient with ulcerative colitis. J Crohns Colitis (2008) 0.80

Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? Med Hypotheses (2010) 0.80

Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy. Eur J Gastroenterol Hepatol (2006) 0.79

Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome. Hepatology (2008) 0.79

Small bowel parasitosis as cause of obscure gastrointestinal bleeding diagnosed by capsule endoscopy. World J Gastrointest Endosc (2010) 0.79

Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis. J Exp Clin Cancer Res (2010) 0.79

Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol (2011) 0.79

Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites. Nephrol Dial Transplant (2005) 0.79

Silent ulcerative colitis adjacent to a regular sigmoid adenocarcinoma. Eur J Gastroenterol Hepatol (2011) 0.79

Successful management of full-length obstructing esophageal bezoars in an intensive care unit. Intensive Care Med (2010) 0.79

Treatment of hepatic hydrothorax with vasoconstrictor drugs. Scand J Gastroenterol (2007) 0.79

Weil's disease in a patient with chronic viral hepatitis and history of alcohol abuse. Intern Med (2008) 0.79

Orbital and optic nerve complications of inflammatory bowel disease. J Crohns Colitis (2012) 0.79

Inflammatory bowel disease and demyelination: more than just a coincidence? Expert Rev Clin Immunol (2014) 0.78

Lung perfusion scan is not superior to contrast-enhanced echocardiography for the diagnosis of the hepatopulmonary syndrome in chronic liver disease. Eur J Gastroenterol Hepatol (2010) 0.78

Long-term anticoagulation therapy for a cirrhotic patient with recurrent deep venous thrombosis. J Gastroenterol Hepatol (2005) 0.78

Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis. J Gastroenterol Hepatol (2005) 0.78

The role of colonoscopy in the management of intestinal obstruction: a 20-year retrospective study. BMC Gastroenterol (2010) 0.78

Recombinant human erythropoietin in patients with inflammatory bowel disease and refractory anemia: a 15-year single center experience. J Crohns Colitis (2011) 0.78

Tumor necrosis factor-alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites. Clin Chem (2005) 0.78

Diagnosis and endoscopic treatment of esophago-bronchial fistula due to gastric heterotopy. World J Gastrointest Endosc (2010) 0.78

Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient. Am J Gastroenterol (2002) 0.77

A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece. Hepatogastroenterology (2003) 0.77

Helicobacter pylori is a major public health priority in western Balkans: an endoscopy referral center experience. Eur J Intern Med (2010) 0.77

Late-onset ulcerative colitis presenting as filiform polyposis. J Crohns Colitis (2010) 0.77

Rifaximin for the prevention of spontaneous bacterial peritonitis. World J Gastroenterol (2012) 0.77

Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment. J Hepatol (2008) 0.77

Antiplatelet antibodies in patients with chronic viral hepatitis receiving interferon-alpha. Hepatogastroenterology (2007) 0.77

Eosinophilic-Crohn overlap colitis and review of the literature. J Crohns Colitis (2011) 0.77

Prevalence of inflammatory bowel disease related dysplasia and cancer in 1500 colonoscopies from a referral center in northwestern Greece. J Crohns Colitis (2010) 0.77

Imipenem-cilastatin induced pure white cell aplasia. Scand J Infect Dis (2005) 0.77

Crohn's disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants. World J Gastroenterol (2007) 0.77